Atlas Trials

Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes

Clinical trial NCT01235260 · COMPLETED

Trial details

NCT number
NCT01235260
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes MellitusFoot UlcerDiabetic FootDiabetic Neuropathies
Start date
2010-03-01
Primary completion
2011-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.